Most engines don't die in a dramatic cloud of smoke on the side of the […] ...

SAN CARLOS, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in a fireside ...

The change to a 1+1 pneumococcal vaccine schedule in England highlights rising inequalities in booster uptake, threatening protection for at-risk children.

Researchers at BITS Pilani Hyderabad Campus develop experimental vaccine against Streptococcus pneumoniae, offering hope for ...

The US Food and Drug Administration has approved the extension of dosing intervals for Regeneron’s EYLEA HD (aflibercept) up ...

Researchers found that simplifying England’s pneumococcal vaccine schedule from 2+1 to 1+1 did not reduce inequalities in ...

Vaccine uptake data has been examined to assess the impact of moving from a '2+1' to a '1+1' Pneumococcal Conjugate Vaccine (PCV) dose schedule on vaccine coverage and health inequalities among ...

Vaccine uptake data have been examined to assess the impact of moving from a "2+1" to a "1+1" Pneumococcal Conjugate Vaccine ...

The inequalities gap in uptake rates of pneumococcal vaccine for vulnerable groups is widening and simplifying the vaccine schedule has not reduced ...

Vaccine uptake data has been examined to assess the impact of moving from a '2+1' to a '1+1' Pneumococcal Conjugate Vaccine (PCV) dose schedule on ...

Overcoming efficacy, safety, and manufacturing hurdles through innovative personalized cancer vaccine design ...

In its graduation from the United Nations’ least developed country (LDC) category to developing category, Bangladesh is ...